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Abstract
Background: Newborn screening has enabled the early diagnosis of Glutaric aciduria type 1, with the possibility of
improving neurological outcomes in affected children. Achieving those outcomes requires parents to effectively
manage their child’s condition by adherence to a strict dietary regime and responding to situations that may
trigger decompensation. The specific information and support needs of this group of parents are unknown.
Methods: A focus group with five parents was conducted to gain insights into the information that parents
needed and the ways in which they accessed and used information to manage their child’s condition. A topic
guide was used to direct the discussion which was recorded and fully transcribed. All participants gave informed
consent. Data were analysed using thematic analysis, a structured approach that contributes to transparency and
validity of results while allowing the integration of predetermined and emerging themes. To ensure rigour, two
researchers were involved in initial coding of data and key analytic decisions.
Results: Two main themes were identified. ‘Understanding the condition’ explored parent’s needs to understand the
scientific complexity of the condition and to be aware of the worst case scenario associated with loss of metabolic
control. ‘Managing the condition’ explained how parents co-ordinated and controlled the involvement of other
carers and parents’ need to be active partners in medical management to feel in control of the situation.
Conclusions: The study highlights the importance of addressing parents’ initial and ongoing informational needs
so they can fulfil their role and protect their child from metabolic harm.
Keywords: Glutaric aciduria type 1, Metabolic condition, Parents, Information, Neurological outcome, Qualitative,
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What is known?
 Early diagnosis of Glutaric aciduria type 1 (GA1)
can improve neurological outcomes in affected
children.
 Treatment involves adherence to a strict dietary
regime and management of situations that can
trigger decompensation.
 Achieving improved outcomes depends on parents.
What is new?
 Parental perspectives on the difficulties of managing
GA1.
 Insights into the types of information parents need
to enable them to care effectively for their child and
the challenges associated with accessing and
comprehending that information.
 Insights into how clinicians could work with parents
to help ensure improved neurological outcomes in
children diagnosed with GA1.
Background
Glutaric aciduria type 1 (GA1), is a rare metabolic condi-
tion with a prevalence of approximately 1 in 100,000
newborns. It is caused by a deficiency of the enzyme
glutaryl-CoA dehydrogenase (GCDH), which is involved
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in the breakdown of the amino acids lysine, hydroxylysine
and tryptophan. When there is little or no function of
GCDH, a build-up of glutaric acid, 3-hydroxyglutaric acid,
and glutaconic acid occurs, which are toxic to the brain.
GA1 traditionally presents with metabolic crisis and en-
cephalopathy during infancy, leading to irreversible brain in-
jury, resulting in permanent dystonia. Intelligence is usually
spared initially till repeated injury. Early detection can po-
tentially change the morbid natural history of this disease by
enabling pre-symptomatic initiation of treatment and man-
agement regimes that reduce the likelihood of encephalo-
pathic crises and improve neurological outcome [1–7] .
Newborn screening for GA1 is established very widely
around the world [8–10] and was incorporated into the
Newborn Screening (NBS) programme in England and
Wales in 2015.
Management of GA1 involves maintenance and emer-
gency regimes. In the maintenance regime, dietary intake of
lysine is strictly controlled and a supplementary amino acid
(lysine free, low tryptophan) formula is given to provide
sufficient protein for growth and development. Carnitine
and micronutrients are supplemented [3]. Bloods are regu-
larly monitored in outpatient clinics. In contrast, the emer-
gency regime is instigated when a child is unwell, such as
during infections, illness, immunisations or surgery, where
there is a risk of encephalopathic crisis triggered by a cata-
bolic state. The emergency regime involves timely admis-
sion to a metabolic ward for administration of high energy
intake, reduction or omission of protein to prevent or re-
verse catabolic states, and additional carnitine supplementa-
tion. The early implementation of the emergency regimen
and increased carnitine supplementation during intercur-
rent illnesses or other periods of metabolic stress remains
the most important treatment in the prevention of neuro-
logical damage. Failure to adhere to these regimes is associ-
ated with poor neurological outcome [3].
Parents play a vital role in managing metabolic conditions
to achieve the health outcomes that early detection through
NBS offers. A limited body of evidence indicates the substan-
tial associated burden. Gramer et al. (2014) surveyed parents
living with a range of conditions detected through the NBS
and found that dietary treatment and diagnoses with risk for
metabolic decompensation despite treatment, were associ-
ated with higher perceived burden for the family [11]. The
experience of raising a child with Medium chain acyl Co-A
dehydrogenase deficiency (MCADD) and Phenylketonuria
(PKU) identified challenges adhering to dietary regimes [12,
13]. In relation to GA1, parents are responsible for ensuring
adherence to dietary treatment and in identifying and
responding to situations that may trigger metabolic decom-
pensation and poor neurological outcomes. Current inter-
national clinical guidelines for diagnosing and managing
GA1 recognise that role and include recommendations for
parental education and support including having ongoing
direct access to metabolic specialists [14]. The informational
needs of parents caring for a child with GA1 have not been
explored. This article addresses that gap in knowledge. It
arose from a public patient information (PPI) meeting with
parents of children with GA1 and explored their informa-
tional needs in the context of discussions about proposed
research.
Methods
We used a descriptive qualitative study design [15], an ap-
proach that seeks to offer comprehensive summary of an
event in the everyday terms of that event, to gain insights
into the information that parents needed and how they had
accessed and used information to manage their child’s con-
dition. We recruited parents of children with GA1 from a
regional metabolic centre and via a national parent’s meta-
bolic support organisation. Parents were approached by
their treating clinician or by an organiser of the support
group and invited to participate. Given the small number of
potential participants, this convenience sampling approach
[16] was deemed most appropriate. Data collection involved
a single focus group discussion. Its purpose, in terms of pa-
tient public participation, was explained prior to the discus-
sion. We secured permission for recording and written
informed consent from all participants.
Data collection involved a single focus group discussion,
selected because we wanted to obtain rich data generated
through group interaction. The discussion was facilitated by
one of the project team (AH) with a topic guide to guide the
discussion. Questions encouraged parents to reflect on their
experiences from the point of diagnosis onwards in terms of
what they had wanted to know about their child’s future,
and to discuss where and how they had accessed information
and the value of that information in enabling them to man-
age their child’s condition. The recorded discussion lasted
135min, and was fully transcribed. Data were analysed using
a thematic analysis approach [17]. This involved initial famil-
iarisation, open inductive coding leading to development of a
thematic structure with themes and sub themes. We all con-
tributed to the analysis to ensure rigour. AH and MY per-
formed the initial analysis. Preliminary themes were refined
through an iterative process involving HP and SY.
Ethical approval was not required for the focus group
because it was conducted for PPI purposes. However, in
view of the rarity of the condition which limited anonym-
ity, we registered the project as service development with
a University Research Ethics Committee (ID: ER5861946,
14th March 2018). Written consent included agreement
from all parents for publication of the findings.
Results
An overview of study participants
Five parents (4 mothers and 1 father) of 4 children contrib-
uted to the discussion. Their children (pseudonymised) were:
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Rachel, 17 years, Alex, 8 years, Peter, 3 years, Matthew 2
years.
Themes
Two themes were identified: ‘understanding the condi-
tion’ and ‘managing the condition.’
Understanding the condition
Parents needed to understand the condition sufficiently to be
able to manage it on a day to day basis and to protect their
child from metabolic harm. This involved ‘grappling with the
science’ and being aware of the ‘worst case scenario.’
Grappling with the science
The parents explained how, when presented with a diag-
nosis of GA1, they needed to understand what the condi-
tion was about. The rarity and the scientific complexity of
the condition made this very challenging. Readily available
internet sources provided an overview of the condition
but were inadequate for their needs. As Peter’s mother ex-
plained, “we wanted concrete evidence and we wanted dir-
ect research papers.” These scientific papers were hard to
access and extremely difficult for the parents to under-
stand. It had taken Rachel’s mother “not being a biochem-
ist, quite a long time to read through it and work it out.”
She justified the importance of grappling with this level of
scientific information, despite the evident challenges:
Whether you understood it or not was something else
but at least we had something to go on … solid hard
scientific stuff … You need to know what you're doing
and what you're trying to do …
Parents also identified the importance of having that
scientific information translated into practically focused,
written information that would help them manage the
condition on a daily basis. A booklet written by a phys-
ician from the USA provided one family with guidance
for ‘sick days management ‘, and had been an invaluable
reference source for Rachel’s mother:
If I didn’t know what to do, I'd just go back and look
at it … . Sometimes, when you're not sure, it's just
clear, 'is it one of those things that might cause a
problem', ‘do I need to worry?’ So yes, I had all the
science, but I also had this handy little guide.
Worst case scenario
Managing a child with GA1 involves being alert to the
ever present threat of metabolic crisis, which can lead to
irreversible neurological damage. Parents explained that
these worst case scenarios dominated most online infor-
mation sources. Although they had found this ‘terrifying’
they emphasised how important it was for parents to
grasp the enormity of the situation so they could under-
stand the importance of their role in managing the condi-
tion and preventing that worst case scenario. As Peter’s
mother stated, “It’s the end of your life, the end of your
chance of a normal life, and they need to know that.”
The parents whose children had been diagnosed clinic-
ally, expressed concerns about how NBS might influence
parental perceptions of the condition and reflected on
the possible implications:
My son had a crisis. We had no idea he had the thing
so no-one is responsible, but if I knew he had this con-
dition and he subsequently had a crisis because I
hadn't acted fast enough or perhaps thought that
things were OK, then I'd never be able to forgive myself.
You need to know. (Peter's mother)
Managing the condition
Parents managed the condition on a daily basis by en-
suring that the strict dietary regime was adhered to. This
involved ‘co-ordinating and controlling intake and in-
volvement’. However, they needed to be ‘active partners
in medical management’ to feel sufficiently in control of
the situation.
Co-ordinating and controlling intake and involvement
Within the family home, activities were carefully co-
ordinated to ensure adherence to the strict dietary regime.
Peter’s family used a checklist on the fridge and Matthew’s
family used a whiteboard to record actions and prevent
omissions or duplications:
We’ve got a big whiteboard in the kitchen and
everything goes up there. So, we’re not confused
between each other. If I’ve done Levo [levo-carnitine -
a dietary supplementary] I put it up there, if [another
family member] has done the jab [injection of Levo-
carnitine], she puts it up there. So, we can go to that
and see that he’s had such and such or that he needs
… (Matthew's mother)
As the child grew older, there was a need to involve
others in caring for their child. The extent to which
other family members were involved was limited, either
because the responsibility was too great for them or be-
cause they could not be trusted to adhere to the dietary
regime:
They [the grandparents] did not want that
responsibility because they were terrified that if
anything happened, relationships would be destroyed.
It’s a huge responsibility. (Rachel's mother)
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That’s been sometimes quite a bit of an issue when we
go to family - trying to give them a little bit meat or
something else – saying it won’t hurt! (Alex's mother)
At some point, however, parents had to delegate some
degree of responsibility for managing the condition to
carers and teachers. This involved making decisions
about who they felt they could trust, ensuring they pro-
vided those carers with information in written and ver-
bal formats to enable them to manage the condition,
and then working with them to develop confidence and
build trust relationships:
The main things that we said … if he’s not himself you
would have to call us immediately, or if you spot a
temperature please medicate him immediately and
then there’s the diet – do not feed him any foods that
we haven’t provided. (Matthew's father)
I went in to the school and met them as well to get it
over to them how important it was. I said I’d rather
them call me a million times. (Alex's mother)
Active partners in the medical management
As partners in care, parents and clinicians needed to de-
velop a shared understanding of medical management
and a common language to discuss it. A fundamental
part of this process was achieving a shared understand-
ing of metabolic stability which was the primary man-
agement goal:
Also, something which took me a long time to pick up
on, when she was young, was this thing about was she
ill? Now what I thought was ill and what the
Metabolic Team meant by ill were two different things
… .when they asked me if she was ill – they meant was
she metabolically unwell. (Rachel's mother)
Ongoing management of GA1 involves making regular
changes to the dietary regime in response to the results
of regular blood tests. Alex’s mother described the
process:
Alex probably has hers every 3 months and then we
generally get a phone call if we need to change her diet
or if her number of protein exchanges is OK.
All the parents had some concerns about this ap-
proach and wanted all the test results to be shared
with them regularly. They suggested this would serve
two main purposes. First, it would give them some
sense of how their child was progressing, and sec-
ondly the act of receiving those results would provide
them with reassurance that the results had been proc-
essed and interpreted.
Just to perhaps see a pattern may be for the parents to
see why they were high and look back on what they've
had to eat that day or that week. (Alex's mother)
You hope that they, whoever’s dealing with your child,
would pick up any anomalies in the results. But I’m
not 100% confident that that would always happen, as
mistakes are made. So, I’d like that information.
(Peter's mother)
Strengths and limitations
The rarity of the condition made recruitment challen-
ging and necessitated the use of convenience sampling.
Using two approaches to recruitment enabled us to con-
duct one focus group. Within this constraint participants
included parents with older children who had been diag-
nosed clinically and parents with children diagnosed
through NBS which contributed to richness of the data.
Notwithstanding this, the scale of the study, sampling
approach and method of data collection are study limita-
tions which restrict generalisability of findings and
claims of saturation. An enhanced recruitment strategy
to identify and recruit a larger number of participants
and either conducting more focus group discussions or
individual semi-structured interviews would have pro-
vided a broader range of experiences and viewpoints and
generated richer data. Additionally, a purposive sampling
approach and collecting demographic information, in-
cluding educational background to ensure we recruited
participants from a wider demographic background,
would have enabled us to achieve data saturation.
Discussion
The findings offer insights into the substantial informa-
tional challenges experienced by parents raising a child
with GA1. Firstly, those associated with achieving a de-
tailed understanding of the condition itself as well as the
management regimes and secondly those associated with
effective information sharing within family and social re-
lationships in order to protect their child from the po-
tential consequences of poor management.
The improved outcomes that newborn screening offers
for those families affected by GA1 depends on adherence
to the dietary regime and rapid responses to metabolic
imbalance [3, 14] Several studies involving Phenylkto-
nuria (PKU), a metabolic condition comparable to GA1
insofar as it is managed by restricting dietary intake of
specific amino acids, have demonstrated a positive asso-
ciation between parental knowledge of the condition and
metabolic control, an indicator of adherence to the
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dietary regime [18–20]. The implications of inadequate
parental knowledge are more profound for GA1 because
this condition has a more acute clinical course than
PKU, if treatment is sub-optimal. The parents in this
study wanted highly complex information in the post
diagnostic period, which was more detailed and in-depth
than that they had received from their metabolic team.
This level of information enabled them to achieve the
sense of control they needed to manage the condition
and keep their child safe. Other studies have similarly
identified discrepancies in the amount of in-depth infor-
mation parents need and receive from health providers
in the post diagnostic period [21, 22]. Although parents
commonly use internet information sources to supple-
ment information received from healthcare providers, to
reduce their anxiety and to enable them to cope better
with their child’s condition [23], they prefer to receive
information about their child’s condition from a trusted
health care provider rather than the internet [24]. Stud-
ies indicate that parents want information in a variety of
formats [22] which enables them to cope better with
their child’s condition. A randomised control study in-
volving parents of children with food allergies found that
those receiving a food allergy handbook for parents had
greater levels of knowledge and confidence, and better
quality of life than those in the control group [25].
The level of understanding acquired by the parents in
our study is unlikely to be accessible to all parents in
their situation. A study involving 42 children with PKU,
reported significantly higher phenylalanine levels (indi-
cating poor adherence to dietary regime) if mothers had
lower levels of education [26]. Our findings indicate the
importance of written materials for parents that contain
sufficient amounts of scientific information translated
into an accessible format and clearly linked to informa-
tion about how to manage the condition. Some materials
are now freely available for parents that address this
need [27, 28]. To ensure that they are fit for purpose, all
materials should be developed using a co-production ap-
proach and involve parents of children with GA1, the
charities established to support them, as well as mem-
bers of the multidisciplinary clinical team including phy-
sicians, dieticians and specialist nurses.
The parents also wanted to be actively involved in moni-
toring their child’s metabolic status and to receive details
of the test results on which dietary management decisions
were based. They wanted to share in the medical manage-
ment and were anxious because they did not receive test
results, fearing that abnormal results may have been
missed by clinicians. Other studies have highlighted the
anxieties associated with receiving them. This relates to
the twofold role that test results play in managing meta-
bolic conditions. As well as informing dietary changes,
they indicate how well the current diet has been adhered
to, effectively providing feedback on parental performance.
This feedback element is associated with considerable
anxiety for parents of children with PKU, particularly
when faced with a child that refuses to eat [13]. These
findings suggest the need for a more detailed insight into
how parents of children with GA1 understand and want
to engage with test results which could then help to in-
form ongoing service improvements.
The extent to which friends and family were involved in
care was very limited. When they needed to involve others
in care, parents assumed educational responsibilities to-
wards the carers. Similar findings have been reported for
other conditions with high treatment management respon-
sibilities, with parents issuing detailed instructions, prepar-
ing educational packs, and spending considerable amounts
of time with nursery and school staff to help them under-
stand the key elements of the condition [12, 13, 29]. The re-
sponsibility for this is substantial and likely to be daunting
for some. Support from specialist nurses was highly valued
by parents of child with MCADD because they were able to
able to convey information in a balanced and non-emotive
way [12]. This type of support may also benefit parents of
children with GA1.
Conclusion
Early detection of GA1 through the NBS programme en-
ables good health outcomes but this is dependent on strict
adherence to dietary regimes, especially when unwell. Par-
ents have a pivotal role in that process. Insights into their
informational needs are valuable for clinicians to inform
the ongoing care and support they provide for parents to
enable them to fulfil their role and protect their child from
metabolic harm. The complexity of the scientific informa-
tion makes this particularly challenging highlighting the
importance of co-production approaches for any initia-
tives to develop materials or ways of working.
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